References
- Imashuku S. Advances in the management of hemophagocytic lymphohistiocytosis. Int J. Hematol. 2000;72:1–11.
- Osugi Y, Hara J, Tagawa S, et al. Cytokine production regulating Thl and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100–3.
- Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-pro-ducing macrophages. Blood. 2005;105: 1648–51.
- Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991;114:387–90.
- Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage acti-vation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129:750–4.
- Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottag-noud P, Spaeth PJ, Neftel KA. Hyperferritinema as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001;68:4–10.
- Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK. Patients with systemic lupus eryth-ematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res 'Ther. 2004;6:295–302.
- Balandraud N, Meynard JB, Auger I, Sovran H, Mugnier B, Reviron D, Roudier J, Roudier C. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003;48:1223–8.
- Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2001;28:865–7.
- Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81:59–61.
- Cortis E, Insalaco A. Macrophage activation syndrome in juve-nile idiopathic arthritis. Acta Paediatr Suppl. 2006;95:38–41.
- Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the liter-ature. Ann Rheum Dis. 2006;65:1596–601.
- Eriksson C, Engstrand S, Sundqvist KG, Rantapaa-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis. 2005;64:403–7.
- Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002;359:579–80.
- De Ryche L, Baeten D, Kruithof E, van den Bosch F, Veys EM, De Keyser F. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reac-tivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum. 2005;52:2192–201.